Phase 4
N=30
Benzocaine Versus Placebo Spray for Pain Relief at Hysterosalpingogram
Pain Relief · Analgesia
Bottom Line
View on ClinicalTrials.gov: NCT01925469 ↗Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Apr 2017
Primary outcome: Primary: Change in Pain Score — 50.6; 70.4 mm — p=0.43
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Benzocaine (Drug); Saline spray (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- University of Pennsylvania
- Primary completion
- Apr 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Pain Score |
50.6; 70.4 | 0.43 |
| SECONDARY Patient Satisfaction |
10; 10; 2; 4; 2; 0 | 0.4 |
| SECONDARY Change in Pain Score From Pre-procedure to 5 Minutes Post Procedure. |
-11.1; -37 | 0.33 |
Summary
The objective of this study is to assess the utility of benzocaine spray versus a placebo spray in alleviating pain during and after hysterosalpingogram (HSG).
Eligibility Criteria
Inclusion Criteria
- All women who present to Penn Fertility Care over the age of 18 years old
Exclusion Criteria
- Patients under the age of 18
- Pregnant patients
- Patients with a history of hypersensitivity to benzocaine
- Patients with a history of asthma or bronchitis
Data sourced from ClinicalTrials.gov (NCT01925469). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.